Limited availability of generic antifungals across the world

Posted by & filed under Uncategorized.

In a global analysis, GAFFI has identified major gaps in antifungal drug provision for common fungal infections. From multiple sources—most directly from individual countries—it shows flucytosine availability in 24% (map), amphotericin B deoxycholate in 49% (map), itraconazole in 93% (map) and fluconazole in 98% (map) of countries (including PEPFAR provision). No vital antifungals are available… Read more »

Burden of serious fungal diseases presented at ECCMID for Czech Republic, Denmark, Germany, Hungary, Vietnam, Ukraine, Iraq & Qatar

Posted by & filed under Uncategorized.

The burden serious fungal disease from 6 European countries, Vietnam, Iraq and Qatar covering a total of 340 million people, has been presented at the ECCMID conference in Barcelona on May 10-13th 2014. The estimate from Vietnam is the first SE Asian country to be modelled. Notably different from other countries include high rates of Candida… Read more »